.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Pot & Head is stocked at 136 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Staten Island, Buffalo, and Rochester. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Pot & Head’s mix concentrated in Flower at 43.71% share with a 5.93% month-over-month gain despite a 18.23% year-over-year decline, while Pre-Roll fell to 23.43% share with a 12.85% month-over-month drop and a 62.84% year-over-year contraction. Concentrates held 21.94% share but declined 6.93% month over month and 40.31% year over year, and Vapor Pens at 10.93% share slipped 11.55% month over month with no year-over-year read available. With overall brand sales down 34.75% year over year and average price up 30.36% to $29.24, the pattern implies a pivot toward higher-price-per-unit segments has not offset volume losses, leaving Flower as the relative stabilizer within a broadly contracting mix.
The shift—Flower’s month-over-month uptick alongside double-digit contractions in Pre-Roll and Concentrates—implies near-term positioning anchored in core inhalables where elasticity may be moderating, while higher-velocity, lower-price Pre-Rolls are disproportionately sensitive to pullbacks. Holding 21.94% of sales in Concentrates while ranking 28th in Concentrates in New York suggests the brand’s category emphasis outstrips its market rank, pointing to a need to rebalance toward Flower’s 5.93% month-over-month resilience and to triage Pre-Roll’s 12.85% month-over-month slide to prevent further share leakage.
Competitive Landscape
Pot & Head sits at rank 28 in NY Concentrates for August 2026, down 9 positions year over year from rank 19, and 6 positions lower than its May 2026 rank of 22; against its historical context, the brand is 18 slots below its peak at rank 10 from November 2025 and trails category leaders as Mfny (Marijuana Farms New York) held rank 1 year over year while UMAMII jumped from rank 33 to rank 3. Compared with peers, Pot & Head’s 3-month slide of 6 ranks contrasts with Nyce rising from rank 8 year over year to rank 5 and Jetpacks maintaining a top-2 position with a 13.1% YoY sales lift, implying Pot & Head is losing relative velocity in a tier where upward mobility is still occurring and that its current trajectory points to further mid-pack erosion unless the November 2025 peak-level drivers are reactivated.
Notable Products
ADK Kush Hash Infused Pre-Roll (1g) posted the standout move in August 2026 with a +60.8% month-over-month surge to rank 1, while Blue Dream Pre-Roll (1g) plunged -69.3% to rank 2, marking a sharp divergence at the top. Meat Breath Pre-Roll (1g) also fell -11.1% at rank 3, and Tangie Sunrise Pre-Roll (1g) climbed +45.3% at rank 6, indicating volatile intra-category shifts. With seven of the top ten slots held by Pre-Roll SKUs and Flower represented by Blue Dream (28g) at rank 8 with $25,747 in sales, the mix tilts toward Pre-Rolls despite split momentum, implying Pot & Head is concentrating shelf energy on infused and strain-led Pre-Rolls while accepting higher churn within the lineup.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
